FIELD: medicine, pharmaceutics.
SUBSTANCE: what is offered is application of allopurinol or its pharmaceutically acceptable salt for treating or preventing palmoplantar erythrodysesthesia (PPE) induced by fluoropyrimidine chemotherapy, a related method of treating and a pharmaceutical composition for skin application of the same purpose, and the composition does not contain methyl sulphonyl methane or cetomacrogol.
EFFECT: relief, and in 66% of patients - delitescence of PPE symptoms in the absence of toxic effects on allopurinol and compliance of the patients is shown.
12 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USING ALLOPURINOL FOR TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA SYNDROME | 2010 |
|
RU2543325C2 |
| METHOD OF TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA | 2018 |
|
RU2722396C2 |
| COMBINATIONS CONTAINING EPOTHILONES AND ANTIMETABOLITES | 2003 |
|
RU2346686C2 |
| THERAPEUTIC AGENT FOR TREATMENT OF PRECANCEROUS SKIN LESIONS | 2004 |
|
RU2366447C2 |
| ANTINEOPLASTIC COMBINATIONS OF 4-ANILINO-3-CYANOQUINOLINES AND CAPECITABINE | 2009 |
|
RU2498804C2 |
| APILIMOD COMPOSITIONS AND METHODS OF USING THEM IN TREATING COLORECTAL CANCER | 2015 |
|
RU2739992C2 |
| MEDICINAL AGENT FOR TREATMENT OF VIRAL CUTANEOUS AND TUMOR DISEASES | 2002 |
|
RU2302861C2 |
| COMPOSITIONS FOR MUCOSITIS INDUCED BY ANTITUMOUR OR IMMUNOSUPPRESSIVE THERAPY | 2009 |
|
RU2460535C2 |
| ON01910NA ENHANCING ACTIVITY OF CHEMOTHERAPEUTIC AGENT IN DRUG-RESISTANT TUMOURS | 2008 |
|
RU2476239C2 |
| METHOD OF CANCER TREATMENT | 2005 |
|
RU2361589C2 |
